Follow-The-Filings

Featured 13F manager

Paulson & Co. Inc. John Paulson

Jersey City, NJ 20 processed 13Fs on this site · 2021 Q3–2026 Q2

  • $2.6B
  • 8 Positions
  • 2026 Q2
  • −17.2% QoQ
  • Top 5 92.3%

John Paulson files Paulson & Co. Inc. as a Form 13F. The latest book is 2026 Q2 at $2.6B, down 17.2% QoQ, led by Madrigal Pharmaceuticals, Perpetua Resources, and Acadian Asset Management.

Portfolio

2026 Q2 · filed 8/14/2026 · 8 long

top 5 92.3% · top 10 100.0%

AUM over time

2026 Q2 $2.6B −17.2% QoQ
2021 Q3 · $3.5B 2021 Q3 · $3.5B
Q3 2021
2021 Q4 · $3.2B · −7.6% QoQ 2021 Q4 · $3.2B · −7.6% QoQ
Q4
2022 Q1 · $3.2B · +0.2% QoQ 2022 Q1 · $3.2B · +0.2% QoQ
Q1 2022
2022 Q2 · $2B · −37.6% QoQ 2022 Q2 · $2B · −37.6% QoQ
Q2
2022 Q3 · $1.4B · −32.6% QoQ 2022 Q3 · $1.4B · −32.6% QoQ
Q3
2022 Q4 · $1.1B · −18.7% QoQ 2022 Q4 · $1.1B · −18.7% QoQ
Q4
2023 Q1 · $1.2B · +8.3% QoQ 2023 Q1 · $1.2B · +8.3% QoQ
Q1 2023
2023 Q2 · $1B · −14.9% QoQ 2023 Q2 · $1B · −14.9% QoQ
Q2
2023 Q3 · $1.1B · +9.2% QoQ 2023 Q3 · $1.1B · +9.2% QoQ
Q3
2023 Q4 · $1.1B · −0.9% QoQ 2023 Q4 · $1.1B · −0.9% QoQ
Q4
2024 Q1 · $1.4B · +30.7% QoQ 2024 Q1 · $1.4B · +30.7% QoQ
Q1 2024
2024 Q2 · $1.4B · −6.6% QoQ 2024 Q2 · $1.4B · −6.6% QoQ
Q2
2024 Q3 · $1.4B · +5.3% QoQ 2024 Q3 · $1.4B · +5.3% QoQ
Q3
2024 Q4 · $1.7B · +15.9% QoQ 2024 Q4 · $1.7B · +15.9% QoQ
Q4
2025 Q1 · $1.7B · +5.8% QoQ 2025 Q1 · $1.7B · +5.8% QoQ
Q1 2025
2025 Q2 · $2B · +15.1% QoQ 2025 Q2 · $2B · +15.1% QoQ
Q2
2025 Q3 · $3B · +47.6% QoQ 2025 Q3 · $3B · +47.6% QoQ
Q3
2025 Q4 · $3.3B · +9.9% QoQ 2025 Q4 · $3.3B · +9.9% QoQ
Q4
2026 Q1 · $3.1B · −4.6% QoQ 2026 Q1 · $3.1B · −4.6% QoQ
Q1 2026
2026 Q2 · $2.6B · −17.2% QoQ 2026 Q2 · $2.6B · −17.2% QoQ
Q2

Book

2023 Q2 2023 Q1 · filed 14 Aug · long equity

BHC - Bausch Health Cos 20.65% Hold 26,439,035 $8.00 $212M
AAMI - Brightsphere Invt Group 18.30% Hold 8,950,121 $20.95 $188M
PPTA - Perpetua Resources 8.88% Hold 24,771,542 $3.67 $91M
NG - Novagold Res 8.66% Hold 22,226,300 $3.99 $89M
MDGL - Madrigal Pharmaceuticals 7.90% New 350,200 $231.00 $81M +350,200 +$81M
AU - Anglogold Ashanti 7.89% Hold 3,833,492 $21.09 $81M
Horizon Therapeutics Pub L 5.02% Reduce −50.0% 500,000 $102.85 $51M −500,000 −$58M
THRY - Thryv 4.80% Hold 2,000,000 $24.60 $49M
AEM - Agnico Eagle Mines 3.82% Hold 783,561 $49.98 $39M
Ssr Mining In 2.77% Hold 2,000,000 $14.18 $28M
THM — 2.51% Hold 61,930,724 $0.4152 $26M
SA - Seabridge Gold 2.44% Hold 2,070,000 $12.05 $25M
NEM - Newmont 1.88% New 452,000 $42.66 $19M +452,000 +$19M
EQX - Equinox Gold 1.12% Hold 2,500,000 $4.58 $11M
Trilogy Metals 0.83% Hold 14,326,996 $0.5935 $9M
Newmark Group · CL A 0.78% Hold 1,284,625 $6.22 $8M
Tellurian 0.74% Hold 5,340,663 $1.41 $8M
Iamgold 0.47% Hold 1,850,000 $2.63 $5M
BABA - Alibaba Group 0.41% Hold 50,000 $83.35 $4M
Iveric Bio 0.10% New 25,000 $39.34 $984K +25,000 +$984K
Diversey 0.04% New 50,000 $8.39 $420K +50,000 +$420K

Exits / last held

not current holdings · last reported size, unchanged · gone vs 2023 Q1

Stock % of portfolio Recent activity Shares Reported price* Value Share change $ change
Shaw Communications · CL B 4.10% Exit 0 $29.92 $49M −1,650,000 −$49M
Yamana Gold 2.82% Exit 0 $5.85 $34M −5,801,500 −$34M
BALL - Ballys 1.45% Exit 0 $19.52 $17M −891,852 −$17M

* Reported price is value ÷ shares from the 13F as of period end — not a live market quote. Weight % is each long-equity position ÷ full 13F AUM, so rows may not sum to 100% when the filing includes options or other non-equity (excluded from this table). Share change and $ change are vs 2023 Q1. Click column headers to sort · click New / Hold / Add / Reduce to promote that move type to the top. Exit opens the last-held block below.

Filings history

20 periods · normalized AUM · open a period for holdings

Period Holdings AUM QoQ Form Filed Filing ID
2026 Q2 8 $2.6B −17.2% 13F-HR 8/14/2026 000101359426000913
2026 Q1 9 $3.1B −4.6% 13F-HR 5/15/2026 000101359426000611
2025 Q4 9 $3.3B +9.9% 13F-HR 2/17/2026 000101359426000257
2025 Q3 10 $3B +47.6% 13F-HR 11/14/2025 000101359425001436
2025 Q2 15 $2B +15.1% 13F-HR 8/14/2025 000101359425001044
2025 Q1 14 $1.7B +5.8% 13F-HR 5/15/2025 000101359425000679
2024 Q4 13 $1.7B +15.9% 13F-HR 2/14/2025 000101359425000309
2024 Q3 15 $1.4B +5.3% 13F-HR 11/14/2024 000101359424000980
2024 Q2 16 $1.4B −6.6% 13F-HR 8/14/2024 000101359424000667
2024 Q1 18 $1.4B +30.7% 13F-HR 5/15/2024 000101359424000487
2023 Q4 17 $1.1B −0.9% 13F-HR 2/14/2024 000101359424000197
2023 Q3 18 $1.1B +9.2% 13F-HR 11/14/2023 000101359423000930
2023 Q2 21 $1B −14.9% 13F-HR 8/14/2023 000101359423000696
2023 Q1 20 $1.2B +8.3% 13F-HR 5/15/2023 000101359423000494
2022 Q4 22 $1.1B −18.7% 13F-HR 2/14/2023 000101359423000262
2022 Q3 28 $1.4B −32.6% 13F-HR 11/14/2022 000156761922020074
2022 Q2 32 $2B −37.6% 13F-HR 8/15/2022 000156761922016238
2022 Q1 33 $3.2B +0.2% 13F-HR 5/16/2022 000156761922011018
2021 Q4 36 $3.2B −7.6% 13F-HR 2/14/2022 000156761922004409
2021 Q3 38 $3.5B 13F-HR 11/15/2021 000156761921020479

About

Paulson & Co. Inc.

20 processed 13Fs on this site · 2021 Q3–2026 Q2

Entity
Paulson & Co. Inc.
Notable person
John Paulson
Location
Jersey City, NJ
All SEC filings
View on sec.gov